Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Breast Neoplasms, Male × Bendamustine Hydrochloride × 90 days × Clear all

Sponsor

Conditions

Leukemia, Lymphocytic, Chronic, B-Cell 10 Lymphoma, Follicular 8 Lymphoma 8 Lymphoma, Mantle-Cell 5 Neoplasms 3 Lymphoma, Non-Hodgkin 3 Lymphoma, Large B-Cell, Diffuse 3 Lymphoma, B-Cell 3 Recurrence 2 Lymphoma, B-Cell, Marginal Zone 2 Leukemia 2 Hodgkin Disease 2 Waldenstrom Macroglobulinemia 1 Sezary Syndrome 1 Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 1 Ovarian Neoplasms 1 Mycosis Fungoides 1 Multiple Myeloma 1 Lymphoproliferative Disorders 1 Lymphomatoid Papulosis 1 Lymphoma, T-Cell, Peripheral 1 Lymphoma, T-Cell, Cutaneous 1 Lymphoma, T-Cell 1 Lymphatic Diseases 1 Immunoproliferative Disorders 1 Immunoblastic Lymphadenopathy 1 Immune System Diseases 1 Hematopoietic and Lymphoid System Neoplasm 1 Hematologic Diseases 1 Fallopian Tube Neoplasms 1

Interventions

exemestane 2 Tamoxifen 2 Leuprolide 2 Letrozole 2 Immunotherapy 2 Goserelin 2 Anastrozole 2 ribociclib 1 acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 1 abemaciclib 1 Neoadjuvant Therapy 1 Immunoenzyme Techniques 1 Everolimus 1 Blood Specimen Collection 1 Biopsy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡